Table 5.
Hormone replacement therapy |
Example regimen: 50–100 μg transdermal estradiol daily |
If uterus is present, add 5–10 mg of medroxyprogesterone acetate for 12 days of the month |
Contraception |
Combined oral contraceptives have the added benefit of providing HRT |
Intrauterine devices or barrier methods are also acceptable alternatives (supplemental HRT should be advised) |
Fertility management |
Options for fertility preservation: ovarian hyperstimulation with oocyte retrieval followed by oocyte or embryo cryopreservation, ovarian tissue cryopreservation |
Ovarian suppression with GnRH agonist prior to chemotherapy |
In vitro fertilization with use of donor oocytes |
Psychosocial support |
Psychologist referral |
Support groups |
Screening |
6–12-month intervals with periodic testing of TSH, calcium, and cortisol levels |
If antiadrenal antibodies are present, an ACTH stimulation test to assess adrenal reserve or referral to an endocrinologist is advised Bone mineral density screening if HRT declined |
Abbreviations: ACTH, adrenocorticotropic hormone; HRT, hormone replacement therapy; TSH, thyroid-stimulating hormone; GnRH, gonadotropin-releasing hormone.